In honour of International Women's Day, EPM brings you a roundup of inspiring commentary from empowering women in the life sciences industries - sharing their personal experiences and tips for inspiring young women wishing to pursue a career in STEM.
Marketing lead at Origin, Steve Brownett-Gale, explores four key trends transforming pharmaceutical packaging in 2023 and the technologies on the horizon.
February 28th marks Rare Disease Day. In keeping with the theme, EPM asked Dr. Asma Patel of Quotient Sciences what barriers remain in rare disease drug development and the strategies that can bring the much-needed drugs to market faster.
In this 2023 prediction piece, Lisa Owens and Jerry Temko, Major, Lindsey & Africa, argue that the life sciences hiring landscape looks set to be busy as companies look to recent big tech redundancies to source data-savvy legal talent.
Berry Global Healthcare is introducing a comprehensive bundle solution to help customers capitalise on the increasing demand for child-resistant (CRC) and tamper-evident (TE) packaging for the pharma and herbal market for syrup and liquid medicines.
Rebekah Jordan spoke with Katrin Pauls (Lonza), Mark Hilhorst (Jekson Vision), and Christoph Jansen (Mettler Toledo), to discuss the factors and challenges involved in the pharma industry's move towards sustainable, future-proofed QC lab testing.
The ideas behind the pharma sector date back to the apothecaries of the middle ages. A naturally progressive industry, pharma has drawn together some great thinkers and speakers
EPM fires some questions with Neil Ward, PacBio, to learn of the trends of 2023, and how its HiFi genome sequencing technology will be used in collaboration with Boston Children's Hospital to uncover novel mutations in rare paediatric diseases.
Nearly half of senior decision-makers working for drug development companies or manufacturers said data silos derailed the efficiency of cross-functional collaboration in their organisation.
SHL Medical discusses the evolution of drug formulations and how it’s supporting cartridge-based subcutaneous drug delivery in redefining the field of patient self-injection.
Kerstin Pohl, sr. global manager, Gene Therapies, at SCIEX, and Thomas Kofoed, co-founder of Alphalyse, discussed the harmful effects of HCPs and strategies to mitigate them.
